Case report · 9 May 2025
Case reportPublished 14 Apr 2017
Bilateral Uveitis and Keratitis Following Nivolumab Treatment for Metastatic Melanoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Inflammatory eye disease has been reported as a side effect with Nivolumab. Case presentation: We report a case of a 92-year-old woman presenting with bilateral and simultaneous keratitis and uveitis in the setting of recurring infusions of nivolumab for metastatic melanoma. The patient underwent successful coordinated treatment of both eyes coinciding with ongoing systemic infusion treatments with ophthalmic topical medications alone. Conclusion: The interest of this case resides in the simultaneous nature of presentation of eye inflammation both internally and of the ocular surface. Prior case reports have cited uveitis or ocular surface disease, however not in simultaneous fashion. Clinicians should raise their index of suspicion of side effects of nivolumab systemic infusion for any vision or eye symptom changes around the timing of treatment.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Medical Case Reports.
Perspective · 5 Feb 2025
A Cancer Research Partnership Training Program Evaluation
Case report · 2025
A Rare Cause of Sepsis in a Patient with Chronic Kidney Disease-A Case Report
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedical Case Reports
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Douglas M Baughman”
- BylineArticles whose byline prints “Cecilia S Lee”
- BylineArticles whose byline prints “Brian E Snydsman”
- BylineArticles whose byline prints “Hoon C Jung”
